Received Apr 11, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MENB | MENINGOCOCCAL B (BEXSERO) | NOVARTIS VACCINES AND DIAGNOSTICS | 2 | UNK | — |
can you still administer the second dose as part of the series; This non-serious case was reported by a nurse via call center representative and described the occurrence of incomplete course of vaccination in a male patient who received Men B NVS (Bexsero) for prophylaxis. Previously administered products included Bexsero (received 1st dose on 14-AUG-2024). On an unknown date, the patient did not receive the 2nd dose of Bexsero. On an unknown date, an unknown time after receiving Bexsero, the patient experienced incomplete course of vaccination (Verbatim: can you still administer the second dose as part of the series). The outcome of the incomplete course of vaccination was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 02-APR-2025 The nurse reported that a patient had a dose 7 months prior, could still administer the second dose as part of the series. Health care professional states that patient was there today to receive 2nd dose of Bexsero. The reporter disconnected chat prior to data being provided. Unknown if patient received 2nd dose on 02-APR-2025. Till the time of reporting, the patient did not receive 2nd dose of Bexsero, which led to incomplete course of vaccination.